IFP Advisors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.83K Sell
2,392
-66
-3% -$183 ﹤0.01% 3838
2026
Q2
$6.37K Buy
2,458
+368
+18% +$1.09K ﹤0.01% 3637
2026
Q1
$6.42K Buy
2,090
+90
+5% +$390 ﹤0.01% 3388
2025
Q4
$7.12K Hold
2,000
– – ﹤0.01% 3236
2025
Q3
$17.8K Sell
2,000
-12
-0.6% -$122 ﹤0.01% 2639
2025
Q2
$18.6K Buy
2,012
+10
+0.5% +$85 ﹤0.01% 2590
2025
Q1
$17.2K Sell
2,002
-35
-2% -$330 ﹤0.01% 2355
2024
Q4
$21.9K Buy
2,037
+37
+2% +$285 ﹤0.01% 2208
2024
Q3
$11.4K Hold
2,000
– – ﹤0.01% 2373
2024
Q2
$8.44K Hold
2,000
– – ﹤0.01% 2399
2024
Q1
$10.2K Hold
2,000
– – ﹤0.01% 2228
2023
Q4
$18.6K Hold
2,000
– – ﹤0.01% 1947
2023
Q3
$13.1K Hold
2,000
– – ﹤0.01% 2148
2023
Q2
$16.3K Hold
2,000
– – ﹤0.01% 2109
2023
Q1
$2.9K Sell
2,000
-1,000
-33% -$10K ﹤0.01% 2774
2022
Q4
$4K Sell
3,000
-1,000
-25% -$10.7K ﹤0.01% 3853
2022
Q3
$5K Hold
4,000
– – ﹤0.01% 3995
2022
Q2
$5K Hold
4,000
– – ﹤0.01% 3750
2022
Q1
$5K Buy
4,000
+2,000
+100% +$24.6K ﹤0.01% 3750
2021
Q4
$35K Hold
2,000
– – ﹤0.01% 1687
2021
Q3
$36K Hold
2,000
– – ﹤0.01% 1712
2021
Q2
$46K Hold
2,000
– – ﹤0.01% 1565
2021
Q1
$30K Sell
2,000
-2,000
-50% -$21.8K ﹤0.01% 1658
2020
Q4
$22K Hold
4,000
– – ﹤0.01% 1750
2020
Q3
$18K Hold
4,000
– – ﹤0.01% 1684
2020
Q2
$20K Hold
4,000
– – ﹤0.01% 1563
2020
Q1
$12K Buy
+4,000
New +$13.9K ﹤0.01% 1686

Other funds holding AVXL

IFP Advisors's AVXL Position: Q3 2026 in Review

IFP Advisors reduced its Anavex Life Sciences (AVXL) stake by 2.7% in Q3 2026, selling an estimated $183 and leaving 2,392 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3838.

IFP Advisors first reported a position in AVXL in Q1 2020 and has held it in 27 quarters since. The position peaked at $46K in Q2 2021. 22 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • IFP Advisors held 2,392 shares of Anavex Life Sciences worth $4.83K as of Q3 2026.
  • IFP Advisors sold 66 Anavex Life Sciences shares in Q3 2026, an estimated $183.
  • Anavex Life Sciences made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3838 holding.
  • IFP Advisors first reported a position in Anavex Life Sciences in Q1 2020 and has held it in 27 quarters since.
  • IFP Advisors's Anavex Life Sciences position peaked at $46K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.